# EDGAR Filing Document

**Accession Number:** 0001435064
**File Stem:** 0001641172-25-013663
**Filing Date:** 2025-6
**Character Count:** 4887
**Document Hash:** 08f7673e46894a851e8acaed3d9735a9
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001641172-25-013663.hdr.sgml**: 20250604

**ACCESSION NUMBER**: 0001641172-25-013663

**CONFORMED SUBMISSION TYPE**: 8-K/A

**PUBLIC DOCUMENT COUNT**: 13

**CONFORMED PERIOD OF REPORT**: 20250603

**ITEM INFORMATION**: Other Events

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20250604

**DATE AS OF CHANGE**: 20250604

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CEMTREX INC
- **CENTRAL INDEX KEY:** 0001435064
- **STANDARD INDUSTRIAL CLASSIFICATION:** ELECTRONIC COMPONENTS & ACCESSORIES [3670]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0930

**FILING VALUES:**
- **FORM TYPE:** 8-K/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-37464
- **FILM NUMBER:** 251024000

**BUSINESS ADDRESS:**
- **STREET 1:** 276 GREENPOINT AVE. BLD 8 SUITE 208
- **CITY:** BROOKLYN
- **STATE:** NY
- **ZIP:** 11222
- **BUSINESS PHONE:** 631 756 9116

**MAIL ADDRESS:**
- **STREET 1:** 276 GREENPOINT AVE. BLD 8 SUITE 208
- **CITY:** BROOKLYN
- **STATE:** NY
- **ZIP:** 11222

?xml version='1.0' encoding='ASCII'?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

**FORM 8-K/A**

**(Amendment No. 1)**

**CURRENT REPORT**

**PURSUANT TO SECTION 13 OR 15(d) OF**

**THE SECURITIES EXCHANGE ACT OF 1934**

**Date of Report (Date of earliest event reported): June 3, 2025**

![](form8-ka_001.jpg)

**<u>Cemtrex Inc.</u>**

(Exact name of registrant as specified in its charter)

Delaware 001-37464 30-0399914 <br> (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.)

135 Fell Court Hauppauge, NY 11788 <br> (Address of principal executive offices) (Zip Code)

Registrant's telephone number, including area code: <u>(631) 756-9116</u>

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4I under the Exchange Act (17 CFR 240.13I(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading symbol** | **Name of each exchange on which registered** |
| Common Stock | CETX | Nasdaq Capital Market |

---

**CURRENT REPORT ON FORM 8-K**

**Cemtrex, Inc.**

**Item 8.01 Other Events.**

As previously reported on a Current Report on Form 8-K filed by Cemtrex, Inc. (the "Company") with the U.S. Securities and Exchange Commission on May 29, 2025, on May 28, 2025, the Company entered into an underwriting agreement (the "Underwriting Agreement") with Aegis Capital Corp. (the "Underwriter"), pursuant to which the Company agreed to sell to the Underwriter, in a firm commitment public offering (the "Offering"), 1,250,000 shares of the Company's common stock, par value $0.001 per share (the "Firm Shares"), for a public offering price of $1.00 per share. The Company also granted the Underwriter a 45-day over-allotment option to purchase up to 187,500 shares of the Company's common stock (the "Option Shares").

On June 2, 2025, the Underwriter fully exercised option, and on June 3, 2025, the Company closed the offering of the Option Shares to the Underwriter, for aggregate gross proceeds of approximately $187,500 less applicable underwriter discounts and other offering fees and expenses.

**Item 9.01 Financial Statements and Exhibits**

(d) Exhibits

<u>Exhibit Number</u> <u>Exhibit Title</u> <br> 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **CEMTREX, INC.** | **CEMTREX, INC.** |
| Date: June 4, 2025 | By: | */s/ Saagar Govil* |
|  |  | Saagar Govil |
|  |  | Chairman, President, and Chief Executive Officer |

---